NCT02583828View on ClinicalTrials.gov

Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients

NACompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2021

Conditions

Breast NeoplasmsNeoplasm Metastasis

Interventions

DRUG

Cyclophosphamide 50mg

DRUG

Letrozole 2.5 mg

Trial Locations (1)

100038

Capital Medical Unvierstiy Cancer Center/ Beijing Shijitan Hospital, Beijing

All Listed Sponsors

lead

Capital Medical University

OTHER

NCT02583828 - Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients | Biotech Hunter | Biotech Hunter